- In July 2024, Apollo Cancer Centres partnered with Accuray to introduce the Indian sub-continent’s first robotic stereotactic radiotherapy program, aiming to enhance precision in cancer treatment through advanced non-invasive technology
- In January 2024, ClearPoint Neuro received FDA clearance for its SmartFrame OR stereotactic system, designed to streamline neurosurgical procedures with greater accuracy and workflow efficiency
